DE69630918D1 - Matrix für Iontophorese - Google Patents

Matrix für Iontophorese

Info

Publication number
DE69630918D1
DE69630918D1 DE69630918T DE69630918T DE69630918D1 DE 69630918 D1 DE69630918 D1 DE 69630918D1 DE 69630918 T DE69630918 T DE 69630918T DE 69630918 T DE69630918 T DE 69630918T DE 69630918 D1 DE69630918 D1 DE 69630918D1
Authority
DE
Germany
Prior art keywords
drug
humectant
weight
iontophoresis
proline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69630918T
Other languages
English (en)
Other versions
DE69630918T2 (de
Inventor
Yasuyuki Suzuki
Katsumi Iga
Yukihiro Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of DE69630918D1 publication Critical patent/DE69630918D1/de
Application granted granted Critical
Publication of DE69630918T2 publication Critical patent/DE69630918T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE69630918T 1995-06-09 1996-06-04 Matrix für Iontophorese Expired - Fee Related DE69630918T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14298395 1995-06-09
JP14298395 1995-06-09
JP20190295 1995-08-08
JP20190295 1995-08-08

Publications (2)

Publication Number Publication Date
DE69630918D1 true DE69630918D1 (de) 2004-01-15
DE69630918T2 DE69630918T2 (de) 2004-10-28

Family

ID=26474826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630918T Expired - Fee Related DE69630918T2 (de) 1995-06-09 1996-06-04 Matrix für Iontophorese

Country Status (5)

Country Link
US (2) US5993848A (de)
EP (1) EP0747092B1 (de)
AT (1) ATE255450T1 (de)
CA (1) CA2178445A1 (de)
DE (1) DE69630918T2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
CA2208332A1 (en) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. Drug administration composition for iontophoresis
EP0922467A3 (de) 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretische Verabreichung von Medikamenten
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
JP4154016B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置およびその組み立て方法
US6322550B2 (en) 1998-04-14 2001-11-27 Hisamitsu Pharmaceutical Co., Inc. Method for transdermal administration of GP IIb/IIIa antagonist
US7089053B1 (en) 1999-10-14 2006-08-08 Pola Chemical Industries Inc Compositions for drug administration by electroporation
JP4868678B2 (ja) * 1999-10-14 2012-02-01 ポーラ化成工業株式会社 エレクトロポーレーション用の組成物
US7498297B2 (en) * 2000-07-18 2009-03-03 Cornell Research Foundation Medicinal uses of mu-opioid receptor agonists
US6801804B2 (en) 2002-05-03 2004-10-05 Aciont, Inc. Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
EP3479838A1 (de) * 2003-02-04 2019-05-08 Cornell Research Foundation, Inc. Verwendung von aromatisch kationischem peptid
AU2005208821B8 (en) * 2003-02-04 2010-10-14 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
EP3381515B1 (de) 2003-05-01 2020-07-08 Cornell Research Foundation, Inc. Trägerkomplexe zur abgabe von molekülen an zellen
JP4615929B2 (ja) * 2004-08-11 2011-01-19 久光製薬株式会社 イオントフォレーシス装置
DE102005024040A1 (de) * 2005-05-25 2006-12-14 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
EP1888001B1 (de) * 2005-06-10 2014-08-06 Syneron Medical Ltd. Patch zur transdermalen wirkstofffreisetzung
WO2007035640A2 (en) 2005-09-16 2007-03-29 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
EP2205967B1 (de) * 2007-10-17 2013-05-01 Syneron Medical Ltd. Überprüfung der auflösungsrate
EP2211918B1 (de) 2007-10-29 2017-10-18 Syneron Medical Ltd. Vertikale pflastertrocknung
JP5453320B2 (ja) 2008-02-07 2014-03-26 コーネル ユニヴァーシティー インスリン抵抗性を防止または処置するための方法
US8143219B2 (en) 2008-02-26 2012-03-27 Cornell University Methods for prevention and treatment of acute renal injury
EP2307546A1 (de) * 2008-06-04 2011-04-13 Coda Therapeutics, Inc. Schmerzbehandlung mit gap-junction-modulationsverbindungen
US20100331265A1 (en) * 2009-03-20 2010-12-30 Tompkins Ronald G Methods for the prevention and treatment of burn injuries and secondary complications
EP2464371B1 (de) * 2009-08-12 2016-03-16 Cornell University Verfahren zur vorbeugung oder behandlung des stoffwechselsyndroms
EP3524256A1 (de) 2009-08-24 2019-08-14 Stealth Peptides International, Inc. Verfahren und zusammensetzungen zur prävention oder behandlung von augenleiden
JP2013506696A (ja) 2009-10-05 2013-02-28 コーネル ユニヴァーシティー 心不全の予防又は処置の方法
WO2013061108A1 (en) 2011-10-28 2013-05-02 Indian Institute Of Technology Madras Piezoelectric devices and methods for their preparation and use
CN104736709A (zh) 2012-03-27 2015-06-24 科达治疗公司 基于钙粘蛋白调节的组合物和治疗
CA2873881A1 (en) 2012-05-18 2013-11-21 Stephen Bruce Fleming Combination treatments and compositions for wound healing

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5612347A (en) * 1988-03-28 1997-03-18 Janssen Pharmaceutica N.V. Agents for preserving or restoring the soundness of the skin
CA2026885C (en) * 1989-02-06 1998-12-01 Keiichirou Okabe Interface for iontophorese
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
CA2123487A1 (en) * 1991-11-12 1993-05-27 Adrian S. Fox Adhesive hydrogels having extended use lives and process for the preparation of same
DE69320378T2 (de) * 1992-01-21 1999-04-29 Macrochem Corp Iontophoretische verbesserte Verabreichung von Medikamenten
JPH08501529A (ja) * 1992-06-11 1996-02-20 セラテック・インコーポレイテッド 皮膚透過薬剤投与緩和のグリセリン使用
JPH0616535A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼ用インターフェイス
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
WO1994002119A1 (en) * 1992-07-23 1994-02-03 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable base composition and drug composition prepared therefrom
EP0643981B1 (de) * 1993-09-22 2002-01-09 Hisamitsu Pharmaceutical Co., Inc. Iontophoresematrix
US5472958A (en) * 1994-08-29 1995-12-05 Abbott Laboratories 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function

Also Published As

Publication number Publication date
EP0747092A2 (de) 1996-12-11
EP0747092A3 (de) 1998-04-08
US6248349B1 (en) 2001-06-19
EP0747092B1 (de) 2003-12-03
DE69630918T2 (de) 2004-10-28
CA2178445A1 (en) 1996-12-10
US5993848A (en) 1999-11-30
ATE255450T1 (de) 2003-12-15

Similar Documents

Publication Publication Date Title
ATE255450T1 (de) Matrix für iontophorese
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
ATE196092T1 (de) Wachstumshormon-enthaltendeproteinformulierung
ATE298561T1 (de) Orale dareichungsform
KR880009632A (ko) 폴리펩티드의 전해식 경피투여
CA2275890A1 (en) Stable liquid interferon formulations
DE69831785D1 (de) Tulobuterol enthaltendes Präparat für perkutane Absorption
ATE177942T1 (de) Lösung, die igf-1 enthält
US6399566B1 (en) Topical preparation for introducing insulin in living organisms
ATE226832T1 (de) Mittel zur arzneistoffverabreichung durch iontophorese
TH19245A (th) วิธีป้องกันการสลายของโปรตีนซี
CA2153787A1 (en) Solution containing igf-1
TH25313A (th) องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่
TH14574EX (th) สารผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee